← Leaderboards
Glyn Dawson
University Of Chicago
$6,616,259
Attributed
$6,616,259
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $543.5K · FY2005–15$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$6,616,259 · 5
By mechanism
R01$4,390,291 · 1
P01$2,165,968 · 2
R13$60,000 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Ceramides”
- Yusuf Awni Hannun · Medical University Of South Carolina$31,236,776
- Besim Ogretmen · Medical University Of South Carolina$16,800,540
- Scott A Summers · Colorado State University-Fort Collins$15,094,141
- Pin-Lan Li · Medical College Of Wisconsin$14,567,134
- Richard N Kolesnick · Sloan-Kettering Inst Can Research$13,993,408
- Susan J Sumner · Research Triangle Institute$13,509,958
Research focus
CeramidesMental RetardationMembrane MicrodomainsBaseNeuronsSignal TransductionCellsBrainEnzymesInhibitor/AntagonistChildPharmaceutical PreparationsSphingolipidsGlycosphingolipidsComplexNerve DegenerationLabelOligodendrogliaEnzyme ActivityProteinsPalmitatesPathway InteractionsCell DeathStructure
Grant awards (29)
Glycosphingolipid Metabolism and Mental Retardation$341,250
R01 · FY2015 · NS · contact PI
Proj 4: Chemical Chaperone Therapy of Batten Disease$192,482
P01 · FY2015 · HD · contact PI
Glycosphingolipid Metabolism and Mental Retardation$337,838
R01 · FY2014 · NS · contact PI
Proj 4: Chemical Chaperone Therapy of Batten Disease$191,771
P01 · FY2014 · HD · contact PI
Glycosphingolipid Metabolism and Mental Retardation$329,307
R01 · FY2013 · NS · contact PI
Proj 4: Chemical Chaperone Therapy of Batten Disease$190,625
P01 · FY2013 · HD · contact PI
Glycosphingolipid Metabolism and Mental Retardation$341,250
R01 · FY2012 · NS · contact PI
Proj 4: Chemical Chaperone Therapy of Batten Disease$198,594
P01 · FY2012 · HD · contact PI
Glycosphingolipid Metabolism and Mental Retardation$341,250
R01 · FY2011 · NS · contact PI
Proj 4: Chemical Chaperone Therapy of Batten Disease$202,285
P01 · FY2011 · HD · contact PI
Glycosphingolipid Metabolism and Mental Retardation$304,920
R01 · FY2010 · NS · contact PI
Glycosphingolipid Metabolism and Mental Retardation$308,000
R01 · FY2009 · NS · contact PI
Glycosphingolipid Metabolism and Mental Retardation$307,750
R01 · FY2008 · NS · contact PI
PATHOGENESIS OF BATTEN DISEASE$118,918
P01 · FY2008 · HD · contact PI
Glycosphingolipid Metabolism and Mental Retardation$301,864
R01 · FY2007 · NS · contact PI
PATHOGENESIS OF BATTEN DISEASE$116,785
P01 · FY2007 · HD · contact PI
PATHOGENESIS OF BATTEN DISEASE$74,543
P01 · FY2006 · HD · contact PI
Glycosphingolipid Metabolism and Mental Retardation$285,099
R01 · FY2005 · NS
PATHOGENESIS OF BATTEN DISEASE$72,373
P01 · FY2005 · HD
Tenth International Congress on Ceroid Lipofuscinoses$30,000
R13 · FY2005 · NS
Glycosphingolipid Metabolism and Mental Retardation$285,151
R01 · FY2004 · NS
PATHOGENESIS OF BATTEN DISEASE$70,265
P01 · FY2004 · HD
Glycosphingolipid Metabolism and Mental Retardation$285,202
R01 · FY2003 · NS
Conference--Neuronal Ceroid Lipofuscinosis$30,000
R13 · FY2003 · NS
Glycosphingolipid Metabolism and Mental Retardation$331,928
R01 · FY2002 · NS
PATHOGENESIS OF BATTEN DISEASE$276,699
P01 · FY2002 · HD
PATHOGENESIS OF BATTEN DISEASE$276,699
P01 · FY2001 · HD
GLYCOSPHINGOLIPID METABOLISM AND MENTAL RETARDATION$289,482
R01 · FY2000 · NS
PATHOGENESIS OF BATTEN DISEASE$183,929
P01 · FY2000 · HD